(NASDAQ:CLRB),(NASDAQ:CLRBW),(NASDAQ:CLRBZ), FLORHAM PARK, N.J., Aug. 07, 2025 (GLOBE NEWSWIRE) — Cellectar Biosciences, Inc. (NASDAQ: CLRB), a late-stage clinical biopharmaceutical company focused on the discovery, development and commercialization of drugs for the treatment of cancer, today announced that the Company will report financial results for the second quarter ended June 30, 2025, and provide a corporate […]

The agreement is a critical step in ensuring adult patients living with NMOSD and gMG have public access to Ultomiris Alexion Pharma Canada Corp., AstraZeneca's Rare Disease group, has entered into a Letter of Intent (LOI) with the pan-Canadian Pharmaceutical Alliance (pCPA) for Ultomiris (ravulizumab) for the treatment of adult patients with anti-aquaporin 4(AQP4)antibody-positive (Ab+)

Star Holdings (NASDAQ: STHO) announced today that it has filed its Quarterly Report on Form 10-Q for the quarter ended June 30, 2025 with the Securities and Exchange Commission. https://mma.prnewswire.com/media/2039485/Star_Holdings_Logo.jpg Net income (loss) attributable to common shareholders for the first quarter was ($39.3 million) and earnings (loss) per share was ($2.95). These results reflect a

Senti Bio Reports Second Quarter 2025 Financial Results and Confirms Next Data Milestone for Phase 1 SENTI-202 Study in Acute Myeloid Leukemia (AML) Expected Q4 2025 GlobeNewswire August 07, 2025 SOUTH SAN FRANCISCO, Calif., Aug. 07, 2025 (GLOBE NEWSWIRE) — Senti Biosciences, Inc. (Nasdaq: SNTI) (“Senti Bio”), a clinical-stage biotechnology company developing next-generation cell and

Beyond Green Welcomes Ten New and Returning Member Properties GlobeNewswire August 07, 2025 NEW YORK, Aug. 07, 2025 (GLOBE NEWSWIRE) — Beyond Green, a global portfolio of some of planet Earth's most sustainable accommodations, is pleased to announce the addition of ten new and returning member properties to its global portfolio between April 1 and

Wuffes Winner Of 2025 Pet Innovation Award For “Dog Hip & Joint Product of the Year” Annual Awards Program Recognizes Companies, Services And Products Within The Rapidly Expanding Pet Industry That Exemplify Excellence & Innovation GlobeNewswire August 07, 2025 NEW YORK, Aug. 07, 2025 (GLOBE NEWSWIRE) — The 2025 Pet Innovation Awards, an independent recognition

EZwhelp Receives “Whelping Product of the Year” In 2025 Pet Innovation Awards Annual Awards Program Recognizes Companies, Services And Products Within The Rapidly Expanding Pet Industry That Exemplify Excellence & Innovation GlobeNewswire August 07, 2025 LOS ANGELES, Aug. 07, 2025 (GLOBE NEWSWIRE) — The 2025 Pet Innovation Awards today announced that EZWhelp, a premier family-owned

Charlee Bear Nuggets Receive 2025 Pet Innovation Award For “Health Focused Dog Treat of the Year” Annual Awards Program Recognizes Companies, Services And Products Within The Rapidly Expanding Pet Industry That Exemplify Excellence & Innovation GlobeNewswire August 07, 2025 LOS ANGELES, Aug. 07, 2025 (GLOBE NEWSWIRE) — The 2025 Pet Innovation Awards today announced that

Dogginstix Beef Collagen UFO Receives 2025 Pet Innovation Award For “Dog Collagen Product of the Year” Annual Awards Program Recognizes Companies, Services And Products Within The Rapidly Expanding Pet Industry That Exemplify Excellence & Innovation GlobeNewswire August 07, 2025 LOS ANGELES, Aug. 07, 2025 (GLOBE NEWSWIRE) — The 2025 Pet Innovation Awards today announced that

Cellectar Biosciences to Report Second Quarter Financial Results and Host a Conference Call on Thursday, August 14, 2025 GlobeNewswire August 07, 2025 FLORHAM PARK, N.J., Aug. 07, 2025 (GLOBE NEWSWIRE) — Cellectar Biosciences, Inc. (NASDAQ: CLRB), a late-stage clinical biopharmaceutical company focused on the discovery, development and commercialization of drugs for the treatment of cancer,